Bellicum Pharmaceuticals Inc Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 21.177K |
Day Range | - - - |
52 Wk Range | 0.060 - 1.310 |
Market Cap | - |
P/E Ratio | - |
Dividend Yield | - |
Exchange | OTC |
RSI | 0 |
Short Interest | - |
Days to Cover | 2.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bellicum Pharmaceuticals Inc (OTC: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals Inc.
The latest price target for Bellicum Pharmaceuticals Inc (OTC: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 2400.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals Inc (OTC: BLCM) is $0.2 last updated December 26, 2023 at 8:26 AM EST.
There are no upcoming dividends for Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals Inc’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals Inc is in the Health Care sector and Biotechnology industry. They are listed on the OTC.